Transmission experiments with Spirochaeta dipodilli Heisch, 1950.

R. B. Heisch

DOI: https://doi.org/10.1080/00034983.1954.11685595

1954-03-01

Annals of Tropical Medicine and Parasitology

Abstract:

What problem does this paper attempt to address?

Comorbid allergy and rhinitis and patient-related outcomes in asthma and COPD: a cross-sectional study

Zainab Al-Hadrawi,Maaike Giezeman,Mikael Hasselgren,Christer Janson,Marta A Kisiel,Karin Lisspers,Scott Montgomery,Anna Nager,Hanna Sandelowsky,Björn Ställberg,Josefin Sundh

DOI: https://doi.org/10.1080/20018525.2024.2397174

2024-08-30

Abstract:Introduction: The study aimed to compare prevalence of comorbid allergic manifestations and rhinitis, allergy testing and associations with patient-related outcomes in patients with asthma and COPD. Methods: Cross-sectional study of randomly selected Swedish patients with a doctor's diagnosis of asthma (n = 1291) or COPD (n = 1329). Self-completion questionnaires from 2014 provided data on demographics, rhinitis, allergic symptoms at exposure to pollen or furry pets, exacerbations, self-assessed severity of disease and scores from the Asthma Control Test (ACT) and the COPD Assessment Test (CAT), and records were reviewed for allergy tests. Results: Allergic manifestations were more common in asthma (75%) compared with COPD (38%). Rhinitis was reported in 70% of asthma and 58% of COPD patients. Allergy tests had been performed during the previous decade in 28% of patients with asthma and in 8% of patients with COPD.In patients with asthma; comorbid allergy and rhinitis were both independently associated with increased risk for poor asthma symptom control (ACT < 20) (OR [95% CI] 1.41 [1.05 to 1.87] and 2.13 [1.60 to 2.83]), exacerbations (1.58 [1.15 to 2.17] and 1.38 [1.02 to 1.86]), and self-assessed moderate/severe disease (1.64 [1.22 to 2.18] and 1.75 [1.33 to 2.30]). In patients with COPD, comorbid allergy and rhinitis were both independently associated with increased risk for low health status (CAT ≥ 10) (OR [95% CI] 1.46 [1.20 to 1.95] and 2.59 [1.97 to 3.41]) respectively, with exacerbations during the previous six months (1.91 [1.49 to 2.45] and 1.57 [1.23 to 2.01]), and with self-assessed moderate/severe disease (1.70 [1.31 to 2.22] and 2.13 [1.66 to 2.74]). Conclusion: Allergic manifestations and rhinitis are more common in asthma than COPD but associated with worse outcomes in both diseases. This highlights the importance of examining and treating comorbid allergy and rhinitis, not only in asthma but also in COPD.
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision

Jan L. Brożek,Jean Bousquet,Ioana Agache,Arnav Agarwal,Claus Bachert,Sinthia Bosnic-Anticevich,Romina Brignardello-Petersen,G. Walter Canonica,Thomas Casale,Niels H. Chavannes,Jaime Correia de Sousa,Alvaro A. Cruz,Carlos A. Cuello-Garcia,Pascal Demoly,Mark Dykewicz,Itziar Etxeandia-Ikobaltzeta,Ivan D. Florez,Wytske Fokkens,Joao Fonseca,Peter W. Hellings,Ludger Klimek,Sergio Kowalski,Piotr Kuna,Kaja-Triin Laisaar,Désirée E. Larenas-Linnemann,Karin C. Lødrup Carlsen,Peter J. Manning,Eli Meltzer,Joaquim Mullol,Antonella Muraro,Robyn O'Hehir,Ken Ohta,Petr Panzner,Nikolaos Papadopoulos,Hae-Sim Park,Gianni Passalacqua,Ruby Pawankar,David Price,John J. Riva,Yetiani Roldán,Dermot Ryan,Behnam Sadeghirad,Boleslaw Samolinski,Peter Schmid-Grendelmeier,Aziz Sheikh,Alkis Togias,Antonio Valero,Arunas Valiulis,Erkka Valovirta,Matthew Ventresca,Dana Wallace,Susan Waserman,Magnus Wickman,Wojtek Wiercioch,Juan José Yepes-Nuñez,Luo Zhang,Yuan Zhang,Mihaela Zidarn,Torsten Zuberbier,Holger J. Schünemann

DOI: https://doi.org/10.1016/j.jaci.2017.03.050

IF: 14.29

2017-10-01

Journal of Allergy and Clinical Immunology

Abstract:BACKGROUND: Allergic rhinitis (AR) affects 10% to 40% of the population. It reduces quality of life and school and work performance and is a frequent reason for office visits in general practice. Medical costs are large, but avoidable costs associated with lost work productivity are even larger than those incurred by asthma. New evidence has accumulated since the last revision of the Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines in 2010, prompting its update.OBJECTIVE: We sought to provide a targeted update of the ARIA guidelines.METHODS: The ARIA guideline panel identified new clinical questions and selected questions requiring an update. We performed systematic reviews of health effects and the evidence about patients' values and preferences and resource requirements (up to June 2016). We followed the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) evidence-to-decision frameworks to develop recommendations.RESULTS: The 2016 revision of the ARIA guidelines provides both updated and new recommendations about the pharmacologic treatment of AR. Specifically, it addresses the relative merits of using oral H<sub>1</sub>-antihistamines, intranasal H<sub>1</sub>-antihistamines, intranasal corticosteroids, and leukotriene receptor antagonists either alone or in combination. The ARIA guideline panel provides specific recommendations for the choice of treatment and the rationale for the choice and discusses specific considerations that clinicians and patients might want to review to choose the management most appropriate for an individual patient.CONCLUSIONS: Appropriate treatment of AR might improve patients' quality of life and school and work productivity. ARIA recommendations support patients, their caregivers, and health care providers in choosing the optimal treatment.

immunology,allergy
The Heterogeneity Hidden in Allergic Rhinitis and Its Impact on Co-Existing Asthma in Adults: A Population-Based Survey

Leonardo Antonicelli,Pierpaolo Marchetti,Simone Accordini,Roberto Bono,Aurelia Carosso,Lucio Casali,Lucia Cazzoletti,Angelo Corsico,Marcello Ferrari,Alessandro Fois,Gabriele Nicolini,Mario Olivieri,Pietro Pirina,Giuseppe Verlato,Simona Villani,Roberto de Marco

DOI: https://doi.org/10.1159/000442872

2015-01-01

International Archives of Allergy and Immunology

Abstract:BACKGROUND: It has been suggested that there is some overlap between allergic rhinitis (AR), sinusitis and polyposis, but this has not been fully documented. The present study aimed to evaluate the prevalence of these co-existing diseases and their impact on bronchial asthma in the general population of Italy.METHODS: Within the frame of the multicentre Gene Environment Interactions in Respiratory Diseases (GEIRD) study, a postal screening questionnaire including questions about self-reported symptoms of asthma, AR, AR with sinusitis without nasal polyps (AR + SsNP) and AR with sinusitis with nasal polyps (AR + SwNP) was administered. Random samples of subjects aged between 20 and 44 years (n = 5,162) answered the postal questionnaire in 4 Italian centres (Pavia, Sassari, Turin, Verona). In AR subjects, the association among AR only, AR + SsNP, AR + SwNP and bronchial asthma was estimated by the relative risk ratio (RRR) using multinomial regression models.RESULTS: The prevalence of AR in the sample was 25.4% (95% CI 24.2-26.6). A self-reported diagnosis of AR + SsNP and AR + SwNP was reported by 5.7% (95% CI 5.0-6.3) and by 1.2% (95% CI 0.9-1.5) of the subjects, respectively. Current asthma was reported by 17.5% of the AR subjects. In the adjusted multivariate analysis, the risk of having current asthma (RRR = 2.31, 95% CI 1.29-4.15), of having at least 1 asthma attack per year (RRR = 2.30, 95% CI 1.19-4.46) and of having had an emergency department admission for respiratory diseases (RRR = 5.61, 95% CI 1.81-23.92) was higher for subjects with AR + SwNP than subjects with AR only.CONCLUSIONS: The diagnosis of AR in the epidemiological setting includes heterogeneous upper airway diseases that affect the clinical features of AR and its interactions with asthma.

immunology,allergy
Rhinitis control and medication use in a real-world sample of patients with persistent rhinitis or rhinosinusitis: a community pharmacy study

Sophie Scheire,Sophie Germonpré,Els Mehuys,Inge Van Tongelen,An De Sutter,Stephane Steurbaut,Thierry Van Hees,Sophie Demarche,Lies Lahousse,Philippe Gevaert,Koen Boussery

DOI: https://doi.org/10.1016/j.jaip.2024.04.031

IF: 11.022

2024-04-28

The Journal of Allergy and Clinical Immunology In Practice

Abstract:Background Little is known about rhinitis control in real-life, nor about the contribution of treatment-related and patient-related factors. Objective This study aimed to examine the level of rhinitis control and rhinitis medication utilization in patients with persistent rhinitis, and to identify predictors of rhinitis control. Methods A cross-sectional observational study was conducted in patients with persistent rhinitis recruited in community pharmacies. Participants completed the Rhinitis Control Assessment Test (RCAT), and a questionnaire on patient/rhinitis characteristics, and rhinitis medication use. A visual analogue scale (VAS) for nasal symptoms was also completed. Pharmacy dispensing data was used to calculate adherence to intranasal glucocorticoids. Nasal spray technique was evaluated using a standardized checklist. Predictors of rhinitis control were explored using a linear regression model. Results A total of 1514 patients, recruited in 215 pharmacies, participated in the study (mean age 48.7 years, 62% female). Almost 60% exhibited suboptimal rhinitis control (RCAT ≤ 21/30). A 50mm cut-off on the VAS yielded 78.1% sensitivity to identify suboptimal rhinitis control. Participants most frequently used intranasal glucocorticoids (55.6%) and intranasal decongestants (47.4%). Only 10.3% of current nasal spray users demonstrated perfect technique. More than half (54.8%) of glucocorticoid users were identified as underadherent. Female sex, self-reported nasal hyperreactivity, active asthma, and use of oral/intranasal decongestants or nasal saline were identified as predictors of worse rhinitis control. Conclusion Suboptimal rhinitis control was common in this real-life sample of persistent rhinitis patients. Improving use of rhinitis medication may be key to increase disease control.

immunology,allergy
Rhinitis Disease Burden and the Impact of Social Determinants of Health

Sarah K Wise,Yasmin Hamzavi-Abedi,Paavali A Hannikainen,Mahesh Padukudru Anand,Tracy Pitt,Marine Savoure,Elina Toskala

DOI: https://doi.org/10.1016/j.jaip.2024.03.043

Abstract:Social determinants of health (SDHs) have a substantial impact on patient care and outcomes globally, both in low- to middle-income countries and in high-income countries. In the clinic, lack of availability of diagnostic tools, inequities in access to care, and challenges obtaining and adhering to prescribed treatment plans may further compound these issues. This article addresses a case of rhinitis in the context of SDHs and inequities in care that may affect various communities and populations around the world. SDHs may include various aspects of one's financial means, education, access to medical care, environment and living situation, and community factors, each of which could play a role in the rhinitis disease manifestations, diagnosis, and management. Allergic and nonallergic rhinitis are considered from this perspective. Rhinitis epidemiology, disease burden, and risk factors are broadly addressed. Patient evaluation, diagnostic tests, and management options are also reviewed, and issues related to SDHs are noted. Finally, inequities in care, knowledge gaps, and unmet needs are highlighted. It is critical to consider SDHs and care inequities when evaluating and treating patients for rhinitis and other allergic conditions.
The impact of asthma, chronic bronchitis and allergic rhinitis on all-cause hospitalizations and limitations in daily activities: a population-based observational study

Simone Accordini,Angelo Guido Corsico,Lucia Calciano,Roberto Bono,Isa Cerveri,Alessandro Fois,Pietro Pirina,Roberta Tassinari,Giuseppe Verlato,Roberto de Marco

DOI: https://doi.org/10.1186/s12890-015-0008-0

IF: 3.1

2015-02-12

BMC Pulmonary Medicine

Abstract:BackgroundChronic respiratory diseases are a significant cause of morbidity and mortality worldwide. We sought to evaluate the impact of asthma, chronic bronchitis and allergic rhinitis on all-cause hospitalizations and limitations in daily activities in adults.MethodsIn the Gene Environment Interactions in Respiratory Diseases study (2007/2010), a screening questionnaire was mailed to 9,739 subjects aged 20–44 (response rate: 53.0%) and to 3,480 subjects aged 45–64 (response rate: 62.3%), who were randomly selected from the general population in Italy. The questionnaire was used to: identify the responders who had asthma, chronic bronchitis, allergic rhinitis or asthma-like symptoms/dyspnoea/other nasal problems; evaluate the total burden [use of hospital services (at least one ED visit and/or one hospital admission) and number of days with reduced activities (lost working days and days with limited, not work related activities) due to any health problems (apart from accidents and injuries) in the past three months]; evaluate the contribution of breathing problems to the total burden (hospitalizations and number of days with reduced activities specifically due to breathing problems).ResultsAt any age, the all-cause hospitalization risk was about 6% among the subjects without any respiratory conditions, it increased to about 9-12% among the individuals with allergic rhinitis or with asthma-like symptoms/dyspnoea/other nasal problems, and it peaked at about 15-18% among the asthmatics with chronic bronchitis aged 20–44 and 45–64, respectively. The expected number of days with reduced activities due to any health problems increased from 1.5 among the subjects with no respiratory conditions in both the age classes, to 6.3 and 4.6 among the asthmatics with chronic bronchitis aged 20–44 and 45–64, respectively. The contribution of breathing problems to the total burden was the highest among the asthmatics with chronic bronchitis (23-29% of the hospitalization risk and 39-50% of the days with reduced activities, according to age).ConclusionsThe impact of asthma, chronic bronchitis and allergic rhinitis on all-cause hospitalizations and limitations in daily activities is substantial, and it is markedly different among adults from the general population in Italy. The contribution of breathing problems to the total burden also varies according to the respiratory condition.

respiratory system
When patient-reported respiratory symptoms shed light on pathophysiology in adult asthma: a cross-sectional study

Gilles Louis,Benoit Pétré,Bernardo Sousa-Pinto,Jean Bousquet,Éric Van Ganse,Florence Schleich,Renaud Louis

DOI: https://doi.org/10.1038/s41598-024-81745-9

IF: 4.6

2024-12-04

Scientific Reports

Abstract:While studies have demonstrated the impact of asthma symptoms on quality of life, very few studies have investigated the relationship between detailed asthma symptoms, as reported by the patient, and lung function and inflammation. A cross-sectional study was conducted on treated (ICS/LABA) adult (> 18 years) asthma patients recruited from the Liege University Hospital Asthma Clinic (Belgium) between 2018 and 2023 ( n = 505). The intensity of asthma symptoms (dyspnea, wheezing, chest tightness, cough, and airway secretion) was measured using five-point Likert scales (5 expressing the greatest intensity). Multiple linear regression models including all independent variables were carried out to evaluate whether lung function and inflammatory parameters were independently associated with distinct symptoms. Cough associated with female gender ( p < 0.05), smoking ( p < 0.01), low FeNO ( p < 0.05) and FEV1% pred. ( p < 0.05), and high blood and sputum eosinophils ( p < 0.05 for both). Airway secretion associated with smoking ( p < 0.05). Chest tightness associated with young age ( p < 0.001), female gender ( p < 0.05) and low FEV1% pred. ( p < 0.01). Dyspnea associated with female gender ( p < 0.001), high BMI ( p < 0.05), low FEV1% pred. ( p < 0.0001) and high FEV1/FVC % ( p < 0.01). Wheezing associated with young age ( p < 0.01), high BMI ( p < 0.05), smoking ( p < 0.01), low FEV1% pred. ( p < 0.0001) and high FEV1/FVC % ( p < 0.05). Different respiratory symptoms are associated with distinct demographic, functional and inflammatory features paving the way for personalized therapeutic interventions.

multidisciplinary sciences
The Characteristic Of Asthma Control Among Nasal Diseases Population: Results From A Cross-Sectional Study

Jiangtao Lin,Jie Gao,Kefang Lai,Xin Zhou,Bei He,Jianying Zhou,Changzheng Wang

DOI: https://doi.org/10.1371/journal.pone.0191543

IF: 3.7

2018-01-01

PLoS ONE

Abstract:Asthma affects a large number of patients in China, but comprehensive evaluation of risks associated with poor asthma control in asthmatic patients with nasal diseases was still limited. We conducted this study to provide a comprehensive estimate of asthma control in Chinese asthma patients with combined nasal diseases, to explore the effect of kinds of nasal diseases on the asthma control, and to identify risk factors associated with uncontrolled asthmatic patients with combined nasal diseases. 1756 asthma patients concomitant with nasal diseases aged >= 17 years and representing all regions of mainland China were surveyed. Multivariate logistic regression model with all related demographic characteristics and disease characteristics factors entered was used to identify risk factors associated with uncontrolled asthma. 56.4% of asthmatic patients with combined allergic rhinitis or rhinosinusitis or rhinopolyp remained uncontrolled. Concomitant without allergic rhinitis, younger age, better treatment adherence and higher education level might positively impact asthma control among asthmatic patients with combined nasal diseases. Perennial allergic rhinitis (OR = 1.5, P = 0.021), moderate-severe allergic rhinitis (OR = 2.2, P = 0.001) were all found to significantly increase the risk of uncontrolled asthma among asthma patients with combined allergic rhinitis. The high prevalence of uncontrolled asthma indicates that asthma management among adult Chinese asthmatic patients comorbid with nasal disease is still a challenge. Efforts should be made to raise the awareness of asthma management and to provide sufficient treatment will greatly contribute to improved quality of asthma management. It is possible to minimize the influence of allergic rhinitis on asthma control by improving nasal function, especially for more severe allergic rhinitis and perennial allergic rhinitis.
Chronic rhinosinusitis in Europe - an underestimated disease. A GA2LEN study

D. Hastan,W. J. Fokkens,C. Bachert,R. B. Newson,J. Bislimovska,A. Bockelbrink,P. J. Bousquet,G. Brozek,A. Bruno,S. E. Dahlén,B. Forsberg,M. Gunnbjörnsdóttir,L. Kasper,U. Krämer,M. L. Kowalski,B. Lange,B. Lundbäck,E. Salagean,A. Todo‐Bom,P. Tomassen,E. Toskala,C. M. van Drunen,J. Bousquet,T. Zuberbier,D. Jarvis,P. Burney,A. Todo-Bom

DOI: https://doi.org/10.1111/j.1398-9995.2011.02646.x

IF: 12.4

2011-05-24

Allergy

Abstract:BACKGROUND: Chronic rhinosinusitis (CRS) is a common health problem, with significant medical costs and impact on general health. Even so, prevalence figures for Europe are unavailable. In this study, conducted by the GA²LEN network of excellence, the European Position Paper on Rhinosinusitis and nasal Polyps (EP³OS) diagnostic criteria are applied to estimate variation in the prevalence of Chronic rhinosinusitis (CRS) for Europe.METHOD: A postal questionnaire was sent to a random sample of adults aged 15-75 years in 19 centres in Europe. Participants reported symptoms of CRS, and doctor diagnosed CRS, allergic rhinitis, age, gender and smoking history. Definition of CRS was based on the EP³OS diagnostic criteria: the presence of more than two of the symptoms: (i) nasal blockage, (ii) nasal discharge, (iii) facial pain/pressure or (iv) reduction in sense of smell, for >12 weeks in the past year--with at least one symptom being nasal blockage or discharge.RESULTS: Information was obtained from 57,128 responders living in 19 centres in 12 countries. The overall prevalence of CRS by EP³OS criteria was 10.9% (range 6.9-27.1). CRS was more common in smokers than in nonsmokers (OR 1.7: 95% CI 1.6-1.9). The prevalence of self-reported physician-diagnosed CRS within centres was highly correlated with the prevalence of EP³OS-diagnosed CRS.CONCLUSION: This is the first European international multicentre prevalence study of CRS. In this multicentre survey of adults in Europe, about one in ten participants had CRS with marked geographical variation. Smoking was associated with having CRS in all parts of Europe.

immunology,allergy
The burden of allergic rhinitis is undermanaged in a large proportion of Chinese young adults from Singapore

Qi Yi Ambrose Wong,Jun Jie Lim,Jun Yan Ng,Praneeth Malipeddi,Yi Ying Eliza Lim,Yang Yie Sio,Fook Tim Chew

DOI: https://doi.org/10.1016/j.waojou.2024.100954

2024-08-14

Abstract:Background: Allergic rhinitis (AR) is a nasal disorder characterized by the simultaneous manifestation of at least 2 out of 4 possible symptoms: rhinorrhea, nasal itching, nasal pruritus, and sneezing. Presently, among Chinese young adults from Singapore, we characterised AR phenotypes, established Total Nasal Symptom Score (TNSS) baselines, and examined the management of AR. Methods: Participants completed an investigator-administered International Study of Asthma and Allergies in Childhood (ISAAC) questionnaire and underwent a skin prick test (SPT). Individuals exhibiting sensitization during the SPT while having at least 2 rhinitis symptoms were identified as AR cases, then categorized into Allergic Rhinitis in Asthma (ARIA) classifications. Results: There were 9323 subjects analyzed. AR prevalence was estimated at 35.4%. Rhinorrhea was perceived as the most severe (mean Nasal Symptom Score (mNSS) ± SD: 1.42 ± 0.74), while nasal pruritus was the least severe (mNSS ± SD: 1.24 ± 0.68). Among moderate-severe AR (68.1%), most were affected by either troublesome symptoms (27.7%) or sleep disturbances (18.4%). By ARIA classes, 26.6% were mild intermittent, 5.4% were mild persistent, 50.3% were moderate-severe intermittent, and 17.6% were moderate-severe persistent. The mean TNSS (mTNSS) of AR cases was 4.43 (SD = 2.49) and between AR classifications, the mTNSS was significantly different. Notably, a large proportion of AR cases remained undiagnosed (85.2%), untreated (72.5%), or both (65.4%); 19.8% self-medicated for AR. Conclusions: There was a significant difference in TNSS of the AR phenotypes, and among phenotypes with a higher mTNSS, a large proportion remained untreated, undiagnosed, or both. The evidence indicates an existing burden of AR among Chinese young adults in Singapore which is notably undermanaged.
How patient-reported respiratory symptoms relate to lung function and inflammation in adult asthma

Louis,G.,Petre,B.,Sousa-Pinto,B.,Bousquet,J.,Van Ganse,E.,Schleich,F.,Louis,R.

DOI: https://doi.org/10.1183/13993003.congress-2024.pa4832

IF: 24.3

2024-11-01

European Respiratory Journal

Abstract:Introduction: Knowing which asthma symptom is related to either lung function parameters or inflammatory parameters is important in order to better understand the disease. Objectives: The main goal was to assess the relationship between the five asthma symptoms, as reported by the patient, and lung function and inflammatory parameters. Methods: A cross-sectional study was conducted on treated adult (>18 years) asthmatics recruited from the Liege University Hospital Asthma Clinic (Belgium) between 2018 and 2023 (n=505). The intensity of the asthma symptoms was measured by five-point Likert scales (5 expressed the highest intensity). Multiple linear regression analyses (MLRA) were performed to identify the functional and inflammatory parameters independently associated with each asthma symptom. Results: The mean age of our patients was 51(±16) years and 58%(291) were female. The mean BMI was 27(±5.3). The mean % predicted FEV1 and % FEV1/FVC were 81%(±19) and 74%(±9.7) respectively. The mean cough, airway secretion, chest tightness, dyspnea and wheezing intensity scales were 3(±1), 2.7(±1.2), 2.9(±1.1), 3.4(±1.1) and 2.7(±1.1) respectively. MLRA showed that FEV1% pred., FeNO, blood eosinophils and sputum eosinophils significantly associated with cough intensity (p<0.05 for all). It also revealed that FEV1% pred. and FEV1/FVC% significantly associated with dyspnea (p<0.0001, p<0.01 respectively) and wheezing intensity (p<0.0001, p<0.05 respectively). Finally, only FEV1% pred. significantly associated with chest tightness intensity (p<0.001). Conclusion: Cough associates with T2 inflammatory parameters, while chest tightness, dyspnea and wheezing associate with impaired spirometric indices.

respiratory system
Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry

Ghislaine Scelo,Carlos A Torres-Duque,Jorge Maspero,Trung N Tran,Ruth Murray,Neil Martin,Andrew N Menzies-Gow,Mark Hew,Matthew J Peters,Peter G Gibson,George C Christoff,Todor A Popov,Andréanne Côté,Celine Bergeron,Delbert Dorscheid,J Mark FitzGerald,Kenneth R Chapman,Louis Philippe Boulet,Mohit Bhutani,Mohsen Sadatsafavi,Libardo Jiménez-Maldonado,Mauricio Duran-Silva,Bellanid Rodriguez,Carlos Andres Celis-Preciado,Diana Jimena Cano-Rosales,Ivan Solarte,Maria Jose Fernandez-Sanchez,Patricia Parada-Tovar,Anna von Bülow,Anne Sofie Bjerrum,Charlotte S Ulrik,Karin Dahl Assing,Linda Makowska Rasmussen,Susanne Hansen,Alan Altraja,Arnaud Bourdin,Camille Taille,Jeremy Charriot,Nicolas Roche,Andriana I Papaioannou,Konstantinos Kostikas,Nikolaos G Papadopoulos,Sundeep Salvi,Deirdre Long,Patrick D Mitchell,Richard Costello,Concetta Sirena,Cristina Cardini,Enrico Heffler,Francesca Puggioni,Giorgio Walter Canonica,Giuseppe Guida,Takashi Iwanaga,Mona Al-Ahmad,Désirée Larenas Linnemann,Ulises Garcia,Piotr Kuna,João A Fonseca,Riyad Al-Lehebi,Mariko Siyue Koh,Chin Kook Rhee,Borja G Cosio,Luis Perez de Llano,Diahn-Warng Perng Steve,Erick Wan-Chun Huang,Hao-Chien Wang,Ming-Ju Tsai,Bassam Mahboub,Laila Ibraheem Jaber Salameh,David Jackson,John Busby,Liam G Heaney,Paul Pfeffer,Amanda Grippen Goddard,Eileen Wang,Flavia Hoyte,Michael E Wechsler,Nicholas Chapman,Rohit Katial,Victoria Carter,Lakmini Bulathsinhala,Neva Eleangovan,Con Ariti,Juntao Lyu,David B Price,Celeste Porsbjerg

DOI: https://doi.org/10.1016/j.anai.2023.08.021

Abstract:Background: Investigation for the presence of asthma comorbidities is recommended by the Global Initiative for Asthma because their presence can complicate asthma management. Objective: To understand the prevalence and pattern of comorbidities and multimorbidity in adults with severe asthma and their association with asthma-related outcomes. Methods: This was a cross-sectional study using data from the International Severe Asthma Registry from 22 countries. A total of 30 comorbidities were identified and categorized a priori as any of the following: (1) potentially type 2-related comorbidities, (2) potentially oral corticosteroid (OCS)-related comorbidities, or (3) comorbidities mimicking or aggravating asthma. The association between comorbidities and asthma-related outcomes was investigated using multivariable models adjusted for country, age at enrollment, and sex (ie male or female). Results: Of the 11,821 patients, 69%, 67%, and 55% had at least 1 potentially type 2-related, potentially OCS-related, or mimicking or aggravating comorbidities, respectively; 57% had 3 or more comorbidities, and 33% had comorbidities in all 3 categories. Patients with allergic rhinitis, nasal polyposis, and chronic rhinosinusitis experienced 1.12 (P = .003), 1.16 (P < .001), and 1.29 times (P < .001) more exacerbations per year, respectively, than those without. Patients with nasal polyposis and chronic rhinosinusitis were 40% and 46% more likely (P < .001), respectively, to have received long-term (LT) OCS. All assessed potential OCS-related comorbidities (except obesity) were associated with a greater likelihood of LTOCS use (odds ratios [ORs]: 1.23-2.77) and, except for dyslipidemia, with a greater likelihood of uncontrolled asthma (ORs: 1.29-1.68). All mimicking or aggravating comorbidities assessed were associated with more exacerbations (1.24-1.68 times more), all (except bronchiectasis) with increased likelihood of uncontrolled asthma (ORs: 1.57-1.81), and all (except chronic obstructive pulmonary disease) with increased likelihood of LTOCS use (ORs: 1.37-1.57). A greater number of comorbidities was associated with worse outcomes. Conclusion: In a global study, comorbidity or multimorbidity is reported in most adults with severe asthma and is associated with poorer asthma-related outcomes. Clinical trial registration: The International Severe Asthma Registry database has ethical approval from the Anonymous Data Ethics Protocols and Transparency (ADEPT) committee (ADEPT0218) and is registered with the European Union Electronic Register of Post-Authorization Studies (European Network Centres for Pharmacoepidemiology and Pharmacovigilance [ENCEPP]/DSPP/23720). The study was designed, implemented, and reported in compliance with the European Network Centres for Pharmacoepidemiology and Pharmacovigilance (ENCEPP) Code of Conduct (EMA 2014; EUPAS44024) and with all applicable local and international laws and regulations, and registered with ENCEPP (https://www.encepp.eu/encepp/viewResource.htm?id=48848). Governance was provided by ADEPT (registration number: ADEPT1121).
Impairment of EQ-5D-5L Domains According to Allergic Rhinitis and Asthma Control: A MASK-air Real-World Study

Bernardo Sousa-Pinto,Gilles Louis,Jorge Rodrigues,Antonio Francesco Maria Giuliano,Ilaria Baiardini,Fulvio Braido,Wienczyslawa Czarlewski,Anna Bedbrook,Tari Haahtela,Arunas Valiulis,Luisa Brussino,Lorenzo Cecchi,Alvaro A Cruz,Bilun Gemicioglu,Wytske J Fokkens,Juan Carlos Ivancevich,Ludger Klimek,Helga Kraxner,Piotr Kuna,Maciej Kupczyk,Violeta Kvedariene,Désirée Larenas-Linnemann,Renaud Louis,Rachel Nadif,Marek Niedoszytko,Yoshitaka Okamoto,Markus Ollert,Nikolaos G Papadopoulos,Vincenzo Patella,Ruby Pawankar,Nhân Pham-Thi,Oliver Pfaar,Frederico S Regateiro,Nicolas Roche,Philip W Rouadi,Boleslaw Samolinski,Joaquin Sastre,Marine Savouré,Nicola Scichilone,Aziz Sheikh,Luís Taborda-Barata,Sanna Toppila-Salmi,Arzu Yorgancioglu,Mihaela Zidarn,Josep M Anto,Torsten Zuberbier,G Walter Canonica,Maria Teresa Ventura,João A Fonseca,Benoit Pétré,Jean Bousquet

DOI: https://doi.org/10.1016/j.jaip.2023.08.006

Abstract:Background: EQ-5D-5L (EuroQOL, 5 Domains, 5 Levels) is a widely used health-related quality-of-life instrument, comprising 5 domains. However, it is not known how each domain is impacted by rhinitis or asthma control. Objective: To assess the association between rhinitis or asthma control and the different EQ-5D-5L domains using data from the MASK-air mHealth app. Methods: In this cross-sectional study, we assessed data from all MASK-air users (2015-2021; 24 countries). For the levels of each EQ-5D-5L domain, we assessed rhinitis and asthma visual analog scales (VASs) and the combined symptom-medication score (CSMS). We built ordinal multivariable models assessing the adjusted association between VAS/CSMS values and the levels of each EQ-5D-5L domain. Finally, we compared EQ-5D-5L data from users with rhinitis and self-reported asthma with data from users with rhinitis alone. Results: We assessed 5354 days from 3092 users. We observed an association between worse control of rhinitis or asthma (higher VASs and CSMS) and worse EQ-5D-5L levels. In multivariable models, all VASs and the CSMS were associated with higher levels of pain/discomfort and daily activities. For anxiety/depression, the association was mostly observed for rhinitis-related tools (VAS nose, VAS global, and CSMS), although the presence of self-reported asthma was also associated with worse anxiety/depression. Worse mobility ("walking around") was particularly associated with VAS asthma and with the presence of asthma. Conclusions: A worse rhinitis control and a worse asthma control are associated with higher EQ-5D-5L levels, particularly regarding pain/discomfort and activity impairment. Worse rhinitis control is associated with worse anxiety/depression, and poor asthma control with worse mobility.
Risk Factors Associated with Asthma Control and Quality of Life in Patients with Mild Asthma Without Preventer Treatment, a Cross-Sectional Study

Sofia Eriksson,Maaike Giezeman,Mikael Hasselgren,Christer Janson,Marta A Kisiel,Scott Montgomery,Anna Nager,Hanna Sandelowsky,Björn Ställberg,Josefin Sundh,Karin Lisspers

DOI: https://doi.org/10.2147/JAA.S460051

2024-07-09

Abstract:Purpose: To study risk factors for uncontrolled asthma and insufficient quality of life (QoL) in patients with mild asthma, ie those without preventer treatment. Patients and methods: Patients aged 18-75 years with a doctor's diagnosis of asthma randomly selected from primary and secondary care in Sweden. Mild asthma was defined as self-reported current asthma and no preventer treatment. Data were collected from self-completed questionnaires in 2012 and 2015. Well-controlled asthma was defined as Asthma Control Test (ACT) ≥20 points and no exacerbation and uncontrolled asthma as ACT<20 points and/or at least one exacerbation in the previous six months. QoL was measured by the Mini Asthma Quality of Life Questionnaire (Mini-AQLQ), where a total mean score of ≥ 6 indicated sufficient and < 6 insufficient QoL. Multivariate logistic regression analyses were performed using asthma control and Mini-AQLQ as dependent variables. Asthma control was dichotomized as controlled and uncontrolled asthma and the Mini-AQLQ as sufficient QoL (mean score ≥6) and insufficient QoL (mean score <6). Results: Among 298 patients, 26% had uncontrolled asthma, 40% insufficient QoL and 20% both uncontrolled asthma and insufficient QoL. Age ≥60 years, obesity, daily smoking, rhinitis and inadequate knowledge of asthma self-management were independently associated with poor asthma control. Factors independently associated with insufficient QoL were age ≥60 years, overweight, obesity, rhinitis, sinusitis and inadequate knowledge of asthma self-management. Age ≥60 years, obesity, rhinitis and inadequate knowledge of asthma self-management were independently associated with both uncontrolled asthma and insufficient QoL. Conclusion: Among asthma patients without preventer medication, 26% had uncontrolled asthma and 40% had insufficient asthma-related QoL. Older age, obesity, and rhinitis were risk factors for both poor asthma control and a reduced QoL, but having good knowledge of asthma self-management reduced this risk. Our findings suggest that this group of patients requires further attention and follow-up.
Asthma with Allergic Rhinitis Management in China: a Nationwide Survey of Respiratory Specialists at Tertiary Hospitals.

Nan Su,Jiangtao Lin,Guoliang Liu,Kaisheng Yin,Xin Zhou,Huahao Shen,Ping Chen,Rongchang Chen,Chuntao Liu,Changgui Wu,Jianping Zhao,Yanping Lin

DOI: https://doi.org/10.1002/alr.21449

2014-01-01

Abstract:BackgroundMany asthmatic patients have coexisting allergic rhinitis (AR). This study aims to investigate the compliance of physicians with respiratory medicine specialty (PRMs) to Global Initiative for Asthma (GINA) and Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines during the management of their asthma-AR patients.MethodsThis cross-sectional questionnaire study surveyed the diagnostic methods and treatment patterns for asthma-AR comorbidity by PRMs from 98 hospitals across China.ResultsPRMs reported an estimated prevalence of asthma-AR comorbidity of >30% at their clinics. PRMs with greater work experience and a higher professional title estimated treating a significantly higher proportion of patients with AR within the previous month (p=0.002 and p<0.001, respectively); they also estimated a higher incidence of patients with AR in the autumn (p<0.001 and p<0.001). A higher percentage of PRMs with 11 years work experience prescribed nasal steroids for AR as compared to those with 1 to 10 years experience (56.9% vs 44.7%, p=0.002). A greater proportion of chief physicians used leukotriene modifiers and a lower proportion used antihistamine H-1-receptor blockers for AR as compared to residents (resident vs assistant chief: 27.5% vs 11.6%, p=0.002; and resident vs chief PRMs: 27.5% vs 9.5%, p=0.001).ConclusionPRMs in China demonstrated an up-to-date comprehension of asthma management (>90%); however, knowledge gaps existed in their concepts of AR and asthma-AR comorbidity. Thus, further education is warranted for PRMs regarding the importance of AR in asthma patients, definitive diagnosis (allergy tests), classifications of AR, and treatment guidelines for the asthma-AR comorbidity.
Comparison of Brucella canis genomes isolated from different countries shows multiple variable regions.

M. Sánchez-Jiménez,J. P. Isaza,J. Alzate,M. Olivera-Angel

DOI: https://doi.org/10.1016/j.ygeno.2015.03.004

IF: 4.31

2015-07-01

Genomics

Abstract:
Evaluation of sinonasal involvement in patients with asthma and chronic obstructive pulmonary disease

Omur Aydin,Nilay Orak Akbay,Zahide Ciler Buyukatalay,Fatma Arslan,Ebru Dumlupinar,Zeynep Celebi Sozener,Mustafa Kursat Gokcan,Oznur Yildiz,Yavuz Selim Demirel,Dilsad Mungan

DOI: https://doi.org/10.2500/aap.2024.45.240014

2024-05-01

Allergy and Asthma Proceedings

Abstract:Background: Asthma and chronic obstructive pulmonary disease (COPD) are the most common obstructive diseases. Based on the similarities, we aimed to evaluate sinonasal symptoms in patients with asthma or COPD, and compare the two diseases with regard to upper-airway involvement. Methods: Patients with asthma or with COPD who were followed up at Ankara University Immunology and Allergy or Chest Diseases Departments were included in the study. The participants went through pulmonary function tests, skin-prick tests, and disease severity assessment of either disease. Nasal endoscopic evaluations of all the patients were performed in the Department of Otorhinolaryngology. Lund-Mackay scoring was performed on the computed tomography of the paranasal sinus. Chronic rinosinusitis (CRS) diagnosis was made as recent guidelines. Results: A total of 112 subjects (number of women/men: n = 67/45; median age, 49 years [The range for IQR was 22 years]) were included in the study. Fifty-five patients had asthma, 33 had COPD, and 24 were healthy controls. Nasal symptoms were more frequent in the patients with asthma (patients with asthma, n = 52 [98%]; patients with COPD, n = 17 [52%]; controls, n = 9 [38%]) (p < 0.001). The median (IQR) 22-item Sino-Nasal Outcome Test (SNOT-22) questionnaire score was higher in the patients with asthma (33 [20‐50]) than in the patients with COPD (8 [1.5‐18.7]) and the control group (3.5 [0‐18.7]) (p < 0.01). Patients with asthma had significantly higher prevalence rates of rhinosinusitis than did those in the COPD and the control groups (36%, 15.6%, 8.3%, respectively; p < 0.01). The SNOT-22 optimal cutoff score was calculated as ≥11 to detect the score limit for CRS prediction with the best sensitivity and specificity. Conclusion: As a result, patients with both asthma and COPD may have upper-airway symptoms. CRS, was primarily seen in the patients with asthma. Accordingly, SNOT-22 scores were higher in the patients with asthma than in those in the COPD and the control groups. A referral to the Ear Nose Throat department for further evaluation with nasal endoscopy and computed tomography of the paranasal may be required in a subgroup of patients.

allergy
The Burden of Non-steroidal anti-inflammatory exacerbated respiratory disease from the patient's perspective - a qualitative analysis of posts from the Samter's Society.

Claire Hopkins,Tanya M. Laidlaw,M. Alanin

DOI: https://doi.org/10.4193/rhin19.430

2020-03-01

Abstract:BACKGROUND A subset of patients with chronic rhinosinusitis with nasal polyps and asthma have non-steroidal anti-inflammatory drug exacerbated respiratory disease (N-ERD). Typically, these patients often have more difficult to treat symptoms of both chronic rhinosinusitis and asthma. They also have higher rates of revision after endoscopic sinus surgery. In this paper we aim to include the patient's perspective of living with N-ERD. METHODS In this qualitative study, three months of posts from the Samter's Society Support Group on social media were screened and analysed. RESULTS Thematic analysis revealed eight main themes with subthemes in relation to patient interpretations when living with NERD. Main themes included symptom severity, quality of life, biological treatment options, diet, surgery, medical treatment, lack of awareness of N-ERD, conflicts between medical professionals and the importance of the support group. CONCLUSIONS This study adds to the growing body of evidence that many patients with N-ERD are living with uncontrolled disease which has significant impact on their quality of life. In addition, it has identified important themes that are relevant to know for doctors treating these patients. The results are also important for future research purposes. Finally, it has highlighted the importance of patient advocacy groups in providing support to patients living with chronic disease.

Medicine
A prospective longitudinal study assessing the impact of rhinovirus and bacterial infections in acute exacerbations of chronic rhinosinusitis

Nirushan Narendran,Sophia Volpe,Ibrahim Ramadan,Jacob Ryan Herbert,Bonnie LaFleur,Shireen Samargandy,Christopher H. Le,Eugene H. Chang

DOI: https://doi.org/10.1002/alr.23431

2024-09-05

International Forum of Allergy & Rhinology

Abstract:Background Acute exacerbations of chronic rhinosinusitis (AECRS) are thought to arise from common viral infections progressing to secondary bacterial infections. However, the pathophysiology of AECRS remains poorly understood due to a lack of prospective longitudinal studies. Methods We conducted a one‐year prospective longitudinal study involving chronic rhinosinusitis (CRS) adults. At baseline, we assessed subjective symptom scores using a validated upper respiratory infection questionnaire (WURSS), sinonasal outcome testing scores (SNOT‐22), and endoscopic scores (modified Lund‐Kennedy score). Every 2 weeks, we contacted subjects to collect WURSS and SNOT‐22 scores. If WURSS scores were ≥1 and SNOT‐22 scores were ≥ 8.9 compared with baseline, subjects underwent an AECRS assessment. We identified rhinovirus (RV) incidence through viral nasal brushings at each visit and bacterial infection through bacterial swabs if mucus scores were ≥1. Results Thiry‐five of 80 CRS subjects reported at least one AECRS episode during the year, predominantly occurring in the fall and winter seasons. RV infections were detected in 8 of 35 cases, bacterial infections in 17 of 35, and co‐occurring infections in 7 of 35. All subjects with AECRS visits exhibited significantly higher endoscopic scores compared with baseline. Subjects with co‐occurring RV and bacterial infections demonstrated higher disease severity compared with those with either RV or bacterial infection, or no infection. Conclusions In a one‐year prospective longitudinal study involving CRS adults, we identified significant risk factors for AECRS including seasonality and the presence of RV and bacterial infections. These data suggest a standard definition of AECRS and the need to target RV and bacterial infections if we are to help reduce disease severity.

otorhinolaryngology
Asthma and rhinitis control in adolescents and young adults: A real‐world MASK‐air study

Bernardo Sousa‐Pinto,Arunas Valiulis,Erik Melén,Gerard H. Koppelman,Nikolaos G. Papadopoulos,Mika Makela,Tari Haahtela,Matteo Bonini,Fulvio Braido,Luisa Brussino,Alvaro A. Cruz,Alessandro Fiocchi,Mattia Giovannini,Bilun Gemicioglu,Marek Kulus,Piotr Kuna,Maciej Kupczyk,Violeta Kvedariene,Désirée E. Larenas‐Linnemann,Renaud Louis,Mario Morais‐Almeida,Marek Niedoszytko,Markus Ollert,Oliver Pfaar,Frederico S. Regateiro,Graham Roberts,Boleslaw Samolinski,Marine Savouré,Luis Taborda‐Barata,Sanna Toppila‐Salmi,Maria Teresa Ventura,Marta Vazquez‐Ortiz,Rafael José Vieira,Joao A. Fonseca,Arzu Yorgancioglu,Torsten Zuberbier,Josep M. Anto,Jean Bousquet,Nhân Pham‐Thi,the MASK‐air think tank

DOI: https://doi.org/10.1111/pai.14080

2024-02-03

Pediatric Allergy and Immunology

Abstract:Background In allergic rhinitis and asthma, adolescents and young adult patients are likely to differ from older patients. We compared adolescents, young adults and adults on symptoms, control levels, and medication adherence. Methods In a cross‐sectional study (2015–2022), we assessed European users of the MASK‐air mHealth app of three age groups: adolescents (13–18 years), young adults (18–26 years), and adults (>26 years). We compared them on their reported rhinitis and asthma symptoms, use and adherence to rhinitis and asthma treatment and app adherence. Allergy symptoms and control were assessed by means of visual analogue scales (VASs) on rhinitis or asthma, the combined symptom‐medication score (CSMS), and the electronic daily control score for asthma (e‐DASTHMA). We built multivariable regression models to compare symptoms or medication accounting for potential differences in demographic characteristics and baseline severity. Results We assessed 965 adolescent users (15,252 days), 4595 young adults (58,161 days), and 15,154 adult users (258,796 days). Users of all three age groups displayed similar app adherence. In multivariable models, age groups were not found to significantly differ in their adherence to rhinitis or asthma medication. These models also found that adolescents reported lower VAS on global allergy, ocular, and asthma symptoms (as well as lower CSMS) than young adults and adults. Conclusions Adolescents reported a better rhinitis and asthma control than young adults and adults, even though similar medication adherence levels were observed across age groups. These results pave the way for future studies on understanding how adolescents control their allergic diseases.

pediatrics,immunology,allergy

Transmission experiments with Spirochaeta dipodilli Heisch, 1950.

Comorbid allergy and rhinitis and patient-related outcomes in asthma and COPD: a cross-sectional study

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision

The Heterogeneity Hidden in Allergic Rhinitis and Its Impact on Co-Existing Asthma in Adults: A Population-Based Survey

Rhinitis control and medication use in a real-world sample of patients with persistent rhinitis or rhinosinusitis: a community pharmacy study

Rhinitis Disease Burden and the Impact of Social Determinants of Health

The impact of asthma, chronic bronchitis and allergic rhinitis on all-cause hospitalizations and limitations in daily activities: a population-based observational study

When patient-reported respiratory symptoms shed light on pathophysiology in adult asthma: a cross-sectional study

The Characteristic Of Asthma Control Among Nasal Diseases Population: Results From A Cross-Sectional Study

Chronic rhinosinusitis in Europe - an underestimated disease. A GA2LEN study

The burden of allergic rhinitis is undermanaged in a large proportion of Chinese young adults from Singapore

How patient-reported respiratory symptoms relate to lung function and inflammation in adult asthma

Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry

Impairment of EQ-5D-5L Domains According to Allergic Rhinitis and Asthma Control: A MASK-air Real-World Study

Risk Factors Associated with Asthma Control and Quality of Life in Patients with Mild Asthma Without Preventer Treatment, a Cross-Sectional Study

Asthma with Allergic Rhinitis Management in China: a Nationwide Survey of Respiratory Specialists at Tertiary Hospitals.

Comparison of Brucella canis genomes isolated from different countries shows multiple variable regions.

Evaluation of sinonasal involvement in patients with asthma and chronic obstructive pulmonary disease

The Burden of Non-steroidal anti-inflammatory exacerbated respiratory disease from the patient's perspective - a qualitative analysis of posts from the Samter's Society.

A prospective longitudinal study assessing the impact of rhinovirus and bacterial infections in acute exacerbations of chronic rhinosinusitis

Asthma and rhinitis control in adolescents and young adults: A real‐world MASK‐air study